Market Place
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Please Wait
Applying Filters...
01 1ACETAMINOPHEN
02 1ACTOPLUS MET XR
03 1ALTOPREV
04 1BUDESONIDE
05 2BUPROPION HYDROCHLORIDE
06 1CIPROFLOXACIN EXTENDED RELEASE
07 2DALFAMPRIDINE
08 1DARIFENACIN HYDROBROMIDE
09 1DICLOFENAC SODIUM
10 3DIVALPROEX SODIUM
11 1FELODIPINE
12 1FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
13 1FORTAMET
14 2GLIPIZIDE
15 1GLUCOPHAGE XR
16 1ISOSORBIDE MONONITRATE
17 3LAMOTRIGINE
18 2LEVETIRACETAM
19 1LITHIUM CARBONATE
20 1LORATADINE AND PSEUDOEPHEDRINE SULFATE
21 3METFORMIN HYDROCHLORIDE
22 3METOPROLOL SUCCINATE
23 1MINOLIRA
24 2MORPHINE SULFATE
25 1MOXATAG
26 1NIACIN
27 1NIFEDIPINE
28 1OSMOLEX ER
29 2OXYBUTYNIN CHLORIDE
30 1OXYCONTIN
31 1PALIPERIDONE
32 4QUETIAPINE FUMARATE
33 1RANEXA
34 1RANOLAZINE
35 1REQUIP XL
36 1ROPINIROLE HYDROCHLORIDE
37 1SEROQUEL XR
38 2VENLAFAXINE HYDROCHLORIDE
39 2VERAPAMIL HYDROCHLORIDE
01 121202
02 121316
03 121526
04 121574
05 122008
06 122024
07 122047
08 122104
09 122272
10 150813
11 175395
12 175706
13 176201
14 176467
15 177127
16 177809
17 178503
18 178705
19 178761
20 178906
21 179094
22 190070
23 190161
24 190681
25 190700
26 191093
27 191338
28 191395
29 191544
30 1202383
31 1202498
32 1202774
33 1203370
34 1203578
35 1203755
36 1203983
37 1204161
38 1204203
39 1205209
40 1205457
41 1205634
42 1206811
43 1206863
44 1206928
45 1207138
46 1208643
47 1209116
48 1209269
49 1209410
50 1209635
51 1209993
52 1211143
53 1211544
54 1213085
55 1213247
56 1214419
57 1215478
58 1216916
01 53No
02 5Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90070
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 216916
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : ACETAMINOPHEN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211544
Country : US
Patented : No
Drug : QUETIAPINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90681
Country : US
Patented : No
Drug : GLUCOPHAGE XR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21202
Country : US
Patented : No
Drug : LITHIUM CARBONATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91544
Country : US
Patented : No
Drug : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90700
Country : US
Patented : No
Drug : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78906
Country : US
Patented : No
Drug : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213085
Country : US
Patented : No
Drug : RANEXA
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21526
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
